Hepatitis B s100 Case Discussion - Webinar Available

Date
02 Dec 2019
06:30 PM - 09:00 PM

Cost
Free

Available to
General Practitioners

Continuing Professional Development

RACGP 4 X Cat 2 points; ACRRM 2 x Core PDP points

Event Location
North Western Melbourne PHN
Level 6, 737 Bourke Street
Docklands VIC 3008
Australia

This session will provide community Hepatitis B GP s100 prescribers with an update in topics relevant to the management of people living with HIV. It is a great option for GP HBV Prescribers to discuss cases and network, and for low-caseload GPs to keep up their knowledge and skills

This event is intended to support GPs eligible to prescribe s100 HBV treatment. GPs with complex cases are encouraged to attend, as are low-caseload GPs who can benefit from hearing cases regularly. 

Participants are encouraged to submit their cases for discussion prior to the event. 

This session has been approved for 4 Category 2 RACGP points and ACRRM 2 x Core PDP points, prescribers will also be awarded 1 HBV CPD point for attending, with an additional point allocated if bringing a case.

Outer Metro and regional HBV s100 Prescribers are strongly encouraged to attend via webinar if not able to make it in person. 


Presenter: Associate Professor Benjamin Cowie - Infectious diseases physician and epidemiologist with appointments at The Doherty Institute, the Victorian Department of Health and Human Services, and the University of Melbourne.
Ben has been involved in the development of health public policy in relation to viral hepatitis in Australia and internationally, and in 2015 was named the inaugural Director of the WHO Collaborating Centre for Viral Hepatitis at The Doherty Institute
 


Further Details: 
A light dinner will be provided.
Dinner and registration: 6.30 - 7.00 pm
Session: 7.00 - 9.00 pm
Registrations are essential. RSVP by Wednesday 27th Nov 2019

Learning outcomes:

  • Screen at-risk patients, accurately diagnose CHB infection and assess phase of the disease
  • Monitor patients appropriately, establish suitability for treatment
  • Describe aims of treatment, antiviral treatment options, duration of therapy and definitions of response
  • Monitor patients on treatment according to established protocols, recognise and manage treatment response, resistance, hepatitis flares, & encourage compliance
  • List risk factors, clinical signs, symptoms and complications of advanced liver disease and appropriately manage or refer to specialist care.